Colorectal Neoplasms: all 5,738 studies

Page 16 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.

• A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal CancerTerminatedNCT05983367Phase 2Results posted
• Engaging Black Men in Colorectal Cancer ScreeningCompletedNCT05980182Not applicableResults posted
• ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal CancerTerminatedNCT05824559Phase 1Results posted
• Audio and Video Brochures for Increasing Colorectal Cancer Screening Among Adults Living in AppalachiaCompletedNCT05810714Not applicableResults posted
• Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)CompletedNCT05746195Not applicableResults posted
• Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid TumorsTerminatedNCT05731947Phase 1/2Results posted
• EAGLE Trial CADDIE Artificial Intelligence EndoscopyCompletedNCT05730192Not applicableResults posted
• Community Collaboration to Advance Racial/Ethnic Equity in CRC ScreeningCompletedNCT05714644Not applicableResults posted
• Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings (PainPac)CompletedNCT05686122Not applicableResults posted
• A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal CancerTerminatedNCT05678257Phase 2Results posted
• Flatbush FHC Proactive Colorectal Cancer Screening and NavigationCompletedNCT05646355Not applicableResults posted
• Study of [18F]FAPI-74 PET in Patients With Gastrointestinal CancersCompletedNCT05641896Phase 2Results posted
• A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Patients With Colorectal CancerTerminatedNCT05619172Phase 2Results posted
• A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal CancerActive, not recruitingNCT05609370Phase 1/2Results posted
• A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension StudyCompletedNCT05600309Phase 3Results posted
• Combination Immunotherapy in Colorectal CancerCompletedNCT05571293Phase 2Results posted
• Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15CompletedNCT05546476Phase 2Results posted
• A Study of CTX-009 in Adult Patients With Metastatic Colorectal CancerCompletedNCT05513742Phase 2Results posted
• Colonoscopy Outreach for Rural Communities Aim 2CompletedNCT05453630Not applicableResults posted
• A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerTerminatedNCT05451849Phase 1/2Results posted
• A Study in People With Colorectal Cancer to Test Whether Ezabenlimab or Pembrolizumab in Combination With BI 765063 Lead to Side Effects or Delays in SurgeryTerminatedNCT05446129Phase 1Results posted
• A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid TumoursTerminatedNCT05397171Phase 1/2Results posted
• Improving Colorectal Cancer Screening in Racially Diverse Zip Codes Using Navigation and Machine Learning (PCSNaP)CompletedNCT05383976Results posted
• EO2040 in Combination With Nivolumab, for Treatment of Patients With Minimal Residual Disease of Colorectal CancerTerminatedNCT05350501Phase 2Results posted
• Mailed FIT Outreach 2022CompletedNCT05341622Not applicableResults posted
• Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)TerminatedNCT05330429Phase 2Results posted
• A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal CancerTerminatedNCT05328908Phase 3Results posted
• Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)CompletedNCT05259696Phase 1/2Results posted
• A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid TumorsTerminatedNCT05256381Phase 2Results posted
• Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal CancerTerminatedNCT05223673Phase 3Results posted
• Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C MutationCompletedNCT05198934Phase 3Results posted
• Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid TumorsTerminatedNCT05194735Phase 1/2Results posted
• Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal CarcinomatosisCompletedNCT05185947Phase 2Results posted
• Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal CancerTerminatedNCT05167409Phase 2Results posted
• Michigan Genetic Hereditary Testing (MiGHT)CompletedNCT05162846Not applicableResults posted
• Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Participants With Colorectal CancerCompletedNCT05116085Phase 2Results posted
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)CompletedNCT05104567Phase 2Results posted
• A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive CancersTerminatedNCT05091528Phase 1/2Results posted
• A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid TumorsCompletedNCT05091346Phase 1/2Results posted
• A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)CompletedNCT05064059Phase 3Results posted
• Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)CompletedNCT05061017Phase 2Results posted
• ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTensionActive, not recruitingNCT05056896Early Phase 1Results posted
• KZR-261 in Subjects With Advanced Solid MalignanciesTerminatedNCT05047536Phase 1Results posted
• Technical Feasibility Evaluation of Mucosal Staining During Colon Capsule Endoscopy (CCE) Procedure in Colorectal Cancer (CRC) High Risk Population, When Using MB-MMXCompletedNCT05022719Not applicableResults posted
• SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal StudyTerminatedNCT05010850Not applicableResults posted
• A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.CompletedNCT05004350Phase 2Results posted
• Virtual Health Insurance Navigation Pilot Program for Colorectal SurvivorsCompletedNCT05002608Not applicableResults posted
• e-Motivación: Developing and Pilot Testing an App to Improve Latinos' Screening Colonoscopy RatesCompletedNCT04987788Not applicableResults posted
• Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid TumorsTerminatedNCT04985604Phase 2Results posted
• Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic MetastasesTerminatedNCT04973007Phase 4Results posted
• A Study to Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer After Progression on Standard of Care (SOC)CompletedNCT04907539Phase 2Results posted
• HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of GenomicsActive, not recruitingNCT04905082Not applicableResults posted
• Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008).Active, not recruitingNCT04895722Phase 2Results posted
• Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRCCompletedNCT04890054Not applicableResults posted
• Scottish Vitamin D Intervention StudyCompletedNCT04868227Not applicableResults posted
• HepaSphere™ Microspheres Prospective RegistryCompletedNCT04866290Results posted
• A Study to Evaluate the Safety and Efficacy of Selinexor With or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With RAS MutationsTerminatedNCT04854434Phase 2Results posted
• Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal CancerTerminatedNCT04853043Phase 2Results posted
• A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid TumorsCompletedNCT04853017Phase 1Results posted
• A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic CancerTerminatedNCT04844073Phase 1/2Results posted
• A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 TrialTerminatedNCT04786600Phase 2Results posted
• Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)CompletedNCT04776148Phase 3Results posted
• KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural PracticeCompletedNCT04763824Not applicableResults posted
• Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal CancerCompletedNCT04744831Phase 2Results posted
• Colorectal Cancer and Pre-Cancerous Adenoma Non-Invasive Detection Test StudyCompletedNCT04739722Not applicableResults posted
• Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer PatientsCompletedNCT04737187Phase 3Results posted
• A Sociolinguistic-enabled Web Application to Develop Precision Health Intervention for African AmericansCompletedNCT04705363Not applicableResults posted
• Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on ImplementationCompletedNCT04683744Results posted
• Helping Patients and Providers Make Better Decisions About Colorectal Cancer ScreeningCompletedNCT04683731Not applicableResults posted
• A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsTerminatedNCT04644315Phase 2Results posted
• Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid TumorsTerminatedNCT04628780Phase 1Results posted
• Study of NKTR 255 in Combination With Cetuximab in Solid TumorsCompletedNCT04616196Phase 1/2Results posted
• Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):TerminatedNCT04607668Phase 3Results posted
• A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal CancerActive, not recruitingNCT04607421Phase 3Results posted
• Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer ScreeningCompletedNCT04607291Phase 1Results posted
• Paired Promotion of Colorectal Cancer and Social Determinants of Health ScreeningCompletedNCT04585919Not applicableResults posted
• Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsActive, not recruitingNCT04579380Phase 2Results posted
• A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid TumorsTerminatedNCT04577963Phase 1/2Results posted
• Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and IntestinesActive, not recruitingNCT04535401Phase 1Results posted
• Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX ChemotherapyCompletedNCT04526886Not applicableResults posted
• TheraSphere® For Treatment of Metastases in LiverCompletedNCT04517643Not applicableResults posted
• Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE)TerminatedNCT04515394Phase 2Results posted
• Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-upCompletedNCT04514341Results posted
• Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver MetastasisTerminatedNCT04508140Phase 2Results posted
• Colorectal Cancer Screening Assessment StudyCompletedNCT04500171Not applicableResults posted
• MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)CompletedNCT04495621Phase 1/2Results posted
• Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS)CompletedNCT04492007Not applicableResults posted
• Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal CancersCompletedNCT04491955Phase 2Results posted
• A Study to Evaluate U3-1402 in Subjects With Advanced or Metastatic Colorectal CancerTerminatedNCT04479436Phase 2Results posted
• Multilevel Intervention Based on Colorectal Cancer (CRC) and Cervical Cancer Self-screening in Rural, Segregated AreasCompletedNCT04471194Not applicableResults posted
• Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative ResectionCompletedNCT04457297Phase 3Results posted
• Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)CompletedNCT04456699Phase 3Results posted
• Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal CancersActive, not recruitingNCT04430738Phase 2Results posted
• Accelerating Colorectal Cancer Screening Through Implementation Science in AppalachiaCompletedNCT04427527Not applicableResults posted
• Screen to Save 2: Rural Cancer Screening Educational InterventionCompletedNCT04414306Not applicableResults posted
• Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE)CompletedNCT04406714Not applicableResults posted
• da Vinci SP® Investigational Device Exemption Study in Colorectal ProceduresActive, not recruitingNCT04403022Not applicableResults posted
• Improving Colonoscopy Quality for Colorectal Cancer Screening in the National VA Healthcare SystemCompletedNCT04389957Results posted
• Prevention of Colorectal Cancer Through Multiomics Blood TestingCompletedNCT04369053Results posted
• Axitinib Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Third Line Metastatic Colorectal CancerCompletedNCT04355156Phase 2Results posted

← Colorectal Neoplasms overview